Neurontin

NPR | By Snigdha Prakash,

Michele Norris

Published December 19, 2002 at 12:00 AM EST

Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.

Snigdha Prakash

Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.

Michele Norris

See stories by Michele Norris

WRVO is at a critical moment.

Recent cuts to federal funding are challenging our mission to serve central and upstate New York with trusted journalism, vital local coverage, and the diverse programming that informs and connects our communities. This is the moment to join our community of supporters and help keep journalists on the ground, asking hard questions that matter to our region.

Stand with public media and make your gift today—not just for yourself, but for all who depend on WRVO as a trusted resource and civic cornerstone in central and upstate New York.

Support WRVO now